EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway

Ruoya Wang, Xianzhi Liu, Xiyao Li, Ming Qian, Xi Yang, Qichuan Jiang, Yijie Wang, Hao Liu, Jianguo Chen, Xuefeng Wang, Liang Gong

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Ruoya Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. Hauptthemen laut MEDLINE: Fatty Acid Elongases, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guiding Science and Technology of Jinzhou, Horizontal Research Project of Jinzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was to explore the role of ELOVL6 in the development of head and neck squamous cell carcinoma (HNSCC). Considering its previously identified oncogenic role in hepatocellular carcinoma. ELOVL6 gene expression, clinicopathological analysis, enrichment analysis, and immune infiltration analysis were based on the data from Gene Expression Omnibus and The Cancer Genome Atlas, with additional bioinformatics analyses performed. Human HNSCC tissue microarray and cell lines were used. The expression of ELOVL6 in HNSCC was detected by quantitative polymerase chain reaction, immunohistochemistry assay, and western blot analysis. The proliferation ability of HNSCC cells, invasion, and apoptosis were evaluated using cell counting kit‐8 method, Transwell assay, and flow cytometry, respectively. Based on the data derived from the cancer databases and our HNSCC cell and tissue studies, we found that ELOVL6 was overexpressed in HNSCC. Moreover, ELOVL6 expression level had a positive correlation with clinicopathology of HNSCC. Gene set enrichment analysis showed that ELOVL6 affected the occurrence of HNSCC through WNT signaling pathway. Functional experiments demonstrated that ELOVL6 knockdown inhibited the proliferation and invasion of HNSCC cells while promoting apoptosis. Additionally, compound 3f, an agonist of WNT/β‐catenin signaling pathway, enhances the effect of ELOVL6 on the progression of HNSCC cells. ELOVL6 is upregulated in HNSCC and promotes the development of HNSCC cells by inducing WNT/β‐catenin signaling pathway. ELOVL6 stands a potential target for the treatment of HNSCC and a prognosis indicator of human HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acid ElongasesGene Expression Regulation, NeoplasticHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckWnt Signaling PathwayFemaleHumansMaleApoptosisCell Line, TumorCell MovementCell ProliferationDisease ProgressionPrognosis

Stichwörter der Autor:innen

TCGAextension of long chain fatty acid family member 6head and neck squamous cell carcinomainvasionprognosisproliferation

Substanzen

Fatty Acid ElongasesELOVL6 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Förderung

  • Guiding Science and Technology of Jinzhou
  • Horizontal Research Project of Jinzhou Medical University

Zitieren

APA

Wang, R., Liu, X., Li, X., Qian, M., Yang, X., Jiang, Q., Wang, Y., Liu, H., Chen, J., Wang, X., & Gong, L. (2024). ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23710

Vancouver

Wang R, Liu X, Li X, Qian M, Yang X, Jiang Q, et al. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23710

BibTeX
@article{Wang2024,
  author = {Wang, Ruoya and Liu, Xianzhi and Li, Xiyao and Qian, Ming and Yang, Xi and Jiang, Qichuan and Wang, Yijie and Liu, Hao and Chen, Jianguo and Wang, Xuefeng and Gong, Liang},
  title = {ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23710}
}
Kostenlos starten →